TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biomedica Norden AB
Closing information (x1000 EUR)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
412
|
447
|
395 |
| Financial expenses |
11
|
14
|
17 |
| Earnings before taxes |
-5
|
-2
|
-2 |
| EBITDA |
50
|
62
|
65 |
| Total assets |
248
|
319
|
351 |
| Current assets |
72
|
80
|
57 |
| Current liabilities |
68
|
127
|
165 |
| Equity capital |
35
|
44
|
47 |
| - share capital |
9
|
10
|
10 |
| Employees (average) |
2
|
2
|
2 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
14.1%
|
13.8%
|
13.4% |
| Turnover per employee |
206
|
224
|
198 |
| Profit as a percentage of turnover |
-1.2%
|
-0.4%
|
-0.5% |
| Return on assets (ROA) |
2.4%
|
3.8%
|
4.3% |
| Current ratio |
105.9%
|
63.0%
|
34.5% |
| Return on equity (ROE) |
-14.3%
|
-4.5%
|
-4.3% |
| Change turnover |
1
|
60
|
-7 |
| Change turnover % |
0%
|
15%
|
-2% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.